SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-012680
Filing Date
2018-03-08
Accepted
2018-03-08 18:24:56
Documents
1
Period of Report
2018-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1795
  Complete submission text file 0001140361-18-012680.txt   3492
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BESSEMER TRUST CO. OF DELAWARE, N.A. 1007 NORTH ORANGE STREET, SUITE 1450 WILMINGTON DE 19801
Business Address C/O BESSEMER TRUST CO. OF DELAWARE, N.A. 1007 NORTH ORANGE STREET, SUITE 1450 WILMINGTON DE 19801 302 230 2675
Insys Therapeutics, Inc. Voting Trust (Reporting) CIK: 0001733779 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35902 | Film No.: 18677886